CONMED CORP (CNMD) Stock Income Statement
USA - New York Stock Exchange - NYSE:CNMD - US2074101013 - Common Stock
40.07 USD
-4.17 (-9.43%)
40.11 USD
+0.04 (+0.1%)
| TTM (2025-9-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 1.35B | 1.31B | 1.24B | 1.05B | 1.01B | |||
| Cost Of Goods | 617.34M | 573.98M | 568.50M | 474.20M | 442.60M | |||
| Gross Profit | 730.53M | 733.03M | 676.25M | 571.20M | 568.00M | |||
| Operating Expenses | 594.63M | 523.83M | 554.84M | 501.20M | 457.90M | |||
| Research and Development | 54.16M | 54.43M | 52.60M | 47.20M | 43.60M | |||
| Selling, General, and Administrative Expenses | 523.11M | 371.38M | 296.84M | 420.30M | 381.00M | |||
| Operating Income | 134.56M | 209.20M | 121.40M | 70.10M | 110.10M | |||
| Interest Income/Expense | -32.57M | -37.30M | -39.77M | -28.90M | -35.50M | |||
| Other Income/Expense | N/A | 0.00 | 0.00 | -8.90M | -1.13M | |||
| Non Recurring Items | N/A | -8.88M | -800.00K | -103.10M | -1.50M | |||
| Income Before Taxes | 85.86M | 163.03M | 80.83M | -70.90M | 73.10M | |||
| Income Tax | 21.44M | 30.61M | 16.37M | 9.70M | 10.60M | |||
| Net Income | 64.32M | 132.42M | 64.46M | -80.60M | 62.50M | |||
| EBITDA | 208.80M | 281.06M | 193.28M | 139.70M | 180.80M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | 2.06 | 4.25 | 2.04 | -2.68 | 1.94 | |||
| Non GAAP EPS | 4.52 | 4.16 | 3.45 | 2.65 | 3.21 | |||
| Statistics | ||||||||
| Gross Profit Margin | 54.22% | 56.08% | 54.33% | 54.63% | 56.20% | |||
| Profit Margin | 4.77% | 10.13% | 5.18% | -7.71% | 6.18% | |||
| Operating Profit Margin | 9.99% | 16.01% | 9.75% | 6.70% | 10.89% | |||
All data in USD